- Global Locations -


Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705


Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531


Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates


Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Non-Surgical Bio-Implants Market Overview

The global non-surgical bio-implants market has set a valuation of US$ 27.8 Bn in 2021, and further, is expected to expand at a CAGR of 13.2% to reach US$ 96.0 Bn by the year 2032.

“Increasing adoption of bio-implant procedures and advancements in the bioengineering technologies is expected to uplift the non-surgical bio-implants market growth.”

An implant is a manufactured medical device that is inserted into a human body cavity to replace, support, or augment a biological structure that is missing, damaged, or already present. The prosthesis known as "bio-implants" are used to normalize a person's physiological functions.

The physiology that has been damaged, deregulated, or lost can be effectively restored, replaced, or modulated with injectable bio-implants, a non-surgical therapy approach. The number of people over the age of 60 and above resulted to continue the global trend of rising life expectancy and declining mortality rates.

Globally, the geriatric population is expanding faster than any other age group, demanding an effective and safe treatment for age-related conditions. This has grabbed the attention of non–surgical bio-implants.



Non-Surgical Bio-Implants Market Value in 2021

US$ 27.8 Bn

Non-Surgical Bio-Implants Market Value in 2032

US$ 96.0 Bn

Non-Surgical Bio-Implants Market CAGR (2022-2032)


Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Are The Major Drivers Boosting The Demand For Non-Surgical Bio-Implants Market?

The major drivers for the growth of the non-surgical implants market are growing concern for chronic disorders, a high level of healthcare awareness, and a growing geriatric population. In addition, the growing disposable incomes of people and the rising application areas majorly medical and aesthetic for biomaterials used in non-surgical bio-implants will attribute the market growth.

Furthermore, the advancements in technology in bio-implants and the affordable cost with easy availability of bio-implants are expected to have strong growth in the market. Apart from this, the demand for bio-implants in several medical applications is fuelling market growth.

Which Region Shows Strong Growth Potential In The Non-Surgical Bio-Implants Market?

Owing to a large number of key players and strong healthcare infrastructure, North America is expected to share the highest market for non-surgical bio-implants in the projected years.

Europe is the largest market for non-surgical bio-implants after North America due to the technological advancements in the region, along with increasing government support and funding and rising research and development activities.

Furthermore, due to the increasing geriatric population in the developing countries and high disposable income, the Asia Pacific region is expected to develop a lucrative market for non-surgical bio-implants market in near future.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who Are The Key Players In The Non-Surgical Bio-Implants Market?

Some of the market players operating in the non-surgical bio-implants market are Albiorex International, Moma Therapeutics, Inc., FibroGen, Inc., KYTHERA Biopharmaceuticals, Inc., Novatex Bioengineering SA, Anika Therapeutics, Inc., Johnson & Johnson Private Limited, Fidia Farmaceutici S.p.A., LCA Pharmaceuticals, Hangzhou Gallop Biological Products Co., Ltd., and others.

Scope Of Report

Report Attributes


Growth Rate

CAGR of 13.2% 2022-2032

Base Year for Estimation


Historical Data


Forecast Period


Qualitative Units

Revenue in USD Billion, and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segment Covered

  • Type
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Players

  • Albiorex International
  • Moma Therapeutics, Inc.
  • FibroGen, Inc.
  • KYTHERA Biopharmaceuticals, Inc.
  • Novatex Bioengineering SA
  • Anika Therapeutics, Inc.
  • Johnson & Johnson Private Limited
  • Fidia Farmaceutici S.p.A.
  • LCA Pharmaceuticals
  • Hangzhou Gallop Biological Products Co., Ltd.


Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered In The Non-Surgical Bio-Implants Market Industry Survey

By Type:

  • Non-surgical Bio-implants
    • Viscoaugmentation Bio-implants
    • Viscosupplementation Bio-implants
  • Injectable Biomaterials
    • Collagen
    • Hyaluronan
    • Biopolymers
    • Hydrogels
    • Hydroxyapatite
  • Alloplastic Biomaterials
    • Acrylic Hydrogel

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Growth Outlook for the Global Non-Surgical Bio-Implants Market?

The global non-surgical bio-implants market is anticipated to register a CAGR of 13.2% during the forecast period.

Who are the Top Players in the Global Non-Surgical Bio-Implants Market?

The top players in the global non-surgical bio-implants market are Albiorex International Moma Therapeutics, Inc., FibroGen, Inc., KYTHERA Biopharmaceuticals, Inc., Novatex Bioengineering SA, and others.

Explore Healthcare Insights

View Reports

Non-Surgical Bio-Implants Market

Schedule a Call